Novo Nordisk A/S stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Novo Nordisk A/S stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Novo Nordisk A/S do? Business model and key facts
Get the full picture of Novo Nordisk A/S: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees (FY): 77406
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Stocks related to Novo Nordisk A/S
Selected based on industry alignment and relative market positioning.
Events and news impacting Novo Nordisk A/S stock
Earnings, coporate decisions and industry developments that can affect the share price.
Novo Nordisk A/S fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
